Clincosm LogoSign in Get a demo

recurrent vulvovaginal candidiasis

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Vulvovaginal Candidiasis Trial in Cairo (Blue Light Emitting Diode Therapy, Azole Antifungal)

Enrolling by invitation
  • Recurrent Vulvovaginal Candidiasis
  • Blue Light Emitting Diode Therapy
  • Azole Antifungal
  • Cairo, Egypt
    Faculty of physical therapy, Cairo University
Apr 1, 2023

Invasive Candidiasis, Mucocutaneous Candidiasis, Coccidioidomycosis Trial in Worldwide (Ibrexafungerp)

Active, not recruiting
  • Invasive Candidiasis
  • +9 more
  • Birmingham, Alabama
  • +36 more
Jan 25, 2023

Recurrent Vulvovaginal Candidiasis Trial in Austria, Poland, Slovakia (Prof-001, Fluconazole 150 mg, Placebo cream)

Active, not recruiting
  • Recurrent Vulvovaginal Candidiasis
  • Innsbruck, Tirol, Austria
  • +28 more
Sep 21, 2022

Recurrent Vulvovaginal Candidiasis Trial in United States (Fluconazole Tablet, IBREXAFUNGERP, Placebo oral tablet)

Completed
  • Recurrent Vulvovaginal Candidiasis
  • Fluconazole Tablet
  • +2 more
  • Phoenix, Arizona
  • +24 more
Apr 15, 2022

Recurrent Vulvovaginal Candidiasis Trial in Shenzhen (clotrimazole vaginal tablets, Clotrimazole vaginal tablets+ Lactobacillus)

Recruiting
  • Recurrent Vulvovaginal Candidiasis
  • clotrimazole vaginal tablets
  • Clotrimazole vaginal tablets+ Lactobacillus
  • Shenzhen, Guangdong, China
    Dept Obstetrics and Gynecology
Mar 3, 2022

Recurrent Vulvovaginal Candidiasis Trial in United States (Oteseconazole (VT-1161) 150mg capsule, Fluconazole 150mg capsule,

Completed
Has Results
  • Recurrent Vulvovaginal Candidiasis
  • Oteseconazole (VT-1161) 150mg capsule
  • +2 more
  • Tucson, Arizona
  • +32 more
Feb 3, 2022

Recurrent Vulvovaginal Candidiasis Trial in United States (Oteseconazole (VT-1161), Placebo)

Completed
Has Results
  • Recurrent Vulvovaginal Candidiasis
  • Oteseconazole (VT-1161)
  • Placebo
  • Phoenix, Arizona
  • +13 more
Dec 17, 2021

Recurrent Vulvovaginal Candidiasis Trial in Beijing (SHR8008, Fluconazole)

Recruiting
  • Recurrent Vulvovaginal Candidiasis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 29, 2021

Recurrent Vulvovaginal Candidiasis Trial in Valdemoro (Placebo, Lactobacillus strain)

Not yet recruiting
  • Recurrent Vulvovaginal Candidiasis
  • Placebo
  • Lactobacillus strain
  • Valdemoro, Madrid, Spain
    Hospital Universitario Infanta Elena
Jan 21, 2021

Recurrent Vulvovaginal Candidiasis Trial in United States (VT-1161, Placebo)

Completed
Has Results
  • Recurrent Vulvovaginal Candidiasis
  • Birmingham, Alabama
  • +31 more
Oct 7, 2019

Recurrent Vulvovaginal Candidiasis Trial in Allschwil, Lausanne (PEV7C1, PEV7C9, PEV7B2)

Completed
  • Recurrent Vulvovaginal Candidiasis
  • PEV7C1
  • +3 more
  • Allschwil, Basel, Switzerland
  • +1 more
Dec 21, 2012